🇮🇳 Blincyto in India

Blincyto (blinatumomab) regulatory status in India.

Marketing authorisation

CDSCO

  • Status: likely_approved

Blincyto in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in India

Frequently asked questions

Is Blincyto approved in India?

Yes. CDSCO has authorised it.

Who is the marketing authorisation holder for Blincyto in India?

Amgen is the originator. The local marketing authorisation holder may differ — check the official source linked above.